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RESUMO: “Composição química e efeitos cardiovasculares do óleo essencial de Cymbopogon 
citratus DC. Stapf, Poaceae, em ratos”. C. citratus é utilizada na medicina popular para tratar 
hipertensão. Este trabalho investigou a composição química e os efeitos cardiovasculares do óleo 
essencial do C. citratus (OECC). Foram identificados oito constituintes no OECC, sendo geranial o 
majoritário (43,08%). Em ratos, o OECC (1, 5, 10 e 20 mg/kg, i.v.) induziu hipotensão e bradicardia 
que foram atenuadas pela atropina e tiopental sódico, mas não por L-NAME ou indometacina. Em 
anéis de artéria mesentérica de ratos pré-contraídos com fenilefrina, o OECC (1 a 3000 µg/mL) 
induziu relaxamento que não foi afetado após remoção do endotélio, após TEA ou em anéis pré-
contraídos com KCl (80 mM). Além disso, o OECC (1000 µg/mL) não induziu efeito adicional 
sobre o relaxamento máximo da nifedipina (10 µM). Em conclusão, o OECC induz hipotensão 
possivelmente devido à redução da resistência vascular que pode ser causada por inibição do influxo 
de Ca2+, e bradicardia provavelmente devido à ativação de receptores muscarínicos cardíacos.
Unitermos: Cymbopogon citratus, óleo essencial, efeitos cardiovasculares, ratos.
ABSTRACT: Cymbopogon citratus DC. Stapf, Poaceae, is used in the folk medicine for 
hypertension treatment. This work investigated the chemical composition and cardiovascular 
effects in rats of C. citratus essential oil (EOCC). A phytochemical screening demonstrated the 
presence of eight constituents, being geranial the major compound (43.08%). In rats, EOCC (1, 
5, 10, and 20 mg/kg, i.v.) induced transient hypotension and bradycardia that were attenuated by 
atropine and sodium thiopental, but not by L-NAME or indomethacin. In rings of rat superior 
mesenteric artery pre-contracted with phenylephrine, EOCC (1 to 3000 µg/mL) induced relaxation 
that was not affected after removal of the endothelium, after TEA or in rings pre-contracted with 
KCl (80 mM). Furthermore, EOCC (1000 µg/mL) was not able to induce additional effect on 
maximal relaxation of nifedipine (10 µM). In conclusions, EOCC induces hypotension, possibly by 
reduction in vascular resistance caused by inhibition of the Ca2+ influx, and bradycardia probably 
due to an activation of cardiac muscarinic receptors.
Keywords: Cymbopogon citratus, essential oil, cardiovascular effects, rats.
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INTRODUCTION
 The essential oils are a mixture of volatile 
substances composed mainly of terpenes in addition 
to some other non-terpene components. These volatile 
substances are commonly found in aromatic plants and 
their therapeutic potentials have been lately evaluated 
(Kris-Etherton et al., 2002; Edris, 2007; Paduch et al., 
2007).  
 Studies in animals have demonstrated beneficial 
properties of essential oils in the cardiovascular system 
as antithrombotic, antiplatelet, endothelial protective, 
vasorelaxant and hypotensive activities (Lahlou et al., 
2005; Edris, 2007). Recent reports have showed that 
cardiovascular effects of essential oils also occur in humans 
as improvement in coronary flow (Shiina et al., 2008) and 
hypotensive and bradycardic effects (Dayawansa et al., 
2003).
 Cymbopogon citratus (DC.) Stapf, Poaceae, is 
an aromatic medicinal plant popularly known as “capim-
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santo” and used in the folk medicine as anxyolitic and 
anti-hypertensive. Several pharmacological effects 
were studies such as: analgesic, sedative/hypnotic, 
anxiolytic, anticonvulsant (Viana et al., 2000; Blanco et 
al., 2009). Some studies have shown that the endovenous 
administration of aqueous and hydroalcoholic extracts of 
leaves of C. citratus present anti-hypertensive effect in rats 
(Carbajal et al., 1989; Singi et al., 2005).
 Considering the lack of studies of essential oil of 
C. citratus (EOCC) on the cardiovascular system and it 
use in the folk medicine, the objective of this work was to 
evaluate the hypotensive and vasorelaxant effects of this 
oil in rats.
MATERIALS AND METHODS
 Leaves of Cymbopogon citratus (DC.) Stapf, 
Poaceae, were collected from the garden of medicinal plants 
from Federal University of Sergipe (Brazil). A voucher 
specimen was deposited at Herbarium-ASE of Federal 
University of Sergipe, (code 9391). EOCC was obtained 
from the fresh leaves by hydrodistillation in a Clevenger 
apparatus for 8 h and stored at 4 oC. When required, EOCC 
was dissolved in a saline/cremophor (0.1% v/v) solution, 
for in vivo experiments, or distilled water/cremophor 
(0.1% v/v) solution, for in vitro experiments, at desired 
concentrations.
 The drugs used were: acetylcholine chloride 
(ACh), L-phenylephrine (Phe), NG-nitro-L-arginine 
methyl ester hydrochloride (L-NAME), atropine sulphate, 
indomethacin (INDO), tetraethylammonium (TEA) and 
cremophor (all from Sigma), sodium thiopental (Cristália), 
heparin sodium salt (Roche) and nifedipine (NIF) (RBI). 
The INDO was dissolved with sodium bicarbonate 
(NaHCO3) to 2.5% in saline (m/v), while others drugs were 
freely dissolved in Tyrode solution or saline. All stock 
solutions were maintained at 0 oC and diluted to the desired 
concentration with Tyrode solution (in vitro experiments) 
or saline (in vivo experiments), when necessary. NaHCO3 
and EtOH in used concentrations showed no effect on 
control experiments (data not shown).
 EOCC was analyzed by gas chromatography 
coupled with mass spectrometry (GC/MS) according to 
these experimental conditions: capillary column DB-5MS 
(30m x 0.25mm x 0.25 mm i.d), electron impact 70 eV; 
helium (99.999%) was used as carrier gas at a constant 
flow of 1.2 mL min-1 and an injection volume of 0.5 μL 
(dilution in ethyl acetate); injector temperature 250 °C; 
detector temperature 280 °C. The oven temperature was 
programmed from 50 °C (isothermal for 2 min), with an 
increase of 4 °C/min., to 200 °C, then 10 °C/min to 300 
°C, ending with a 10 min isothermal at 300 °C. Mass 
spectra were taken at 70 eV; a scan interval of 0.5 s and 
fragments from 40 to 550 Da. Quantitative analysis of the 
chemical constituents was performed by flame ionization 
gas chromatography (FID), under same conditions GC-
MS. Identification of individual components of the 
essential oil was performed by computerized matching of 
the acquired mass spectra with those stored in NIST21 and 
NIST107 mass spectral library of the GC-MS data system. 
Retention indices (RI) for all compounds were determined 
according to literature (Van Den Dool & Kratz, 1963) for 
each constituent as previously described (Adams, 2007).
Male Wistar rats (200-300 g) were used in all experiments. 
They were housed in conditions of controlled temperature 
(21±1 ºC) and exposed to a 12 h light-dark cycle with free 
access to food (Purina-Brazil) and tap water. All procedures 
described in the present work are approved by the Animal 
Research Ethics Committee from Universidade Federal de 
Sergipe (CEPA no 31/2007).
 The measurements of the mean arterial pressure 
(MAP) and heart rate (HR) were performed as described 
by Guedes et al. (2004). The MAP and HR were recorded 
before and after administration of EOCC (1, 5, 10 and 20 
mg/kg, i.v., randomly), and after treatment with atropine (2 
mg/kg; i.v.; 15 min.), L-NAME (20 mg/kg; i.v.; 30 min), 
INDO (5 mg/kg, i.v. 30 min) or sodium thiopental (45 mg/
kg; i.p., 60 min), separately. The change of MAP and HR 
for each dose was expressed as percentage of baseline 
values.
 For in vitro experiments, the rings of rat superior 
mesenteric artery (1-2 mm) were isolated and maintained 
according to the technique described by Santos et al. 
(2006).
 The presence of functional endothelium was 
assessed by the ability of acetylcholine to evoke more 
than 70% of relaxation against phenylephrine-induced 
contraction. 
 Values were expressed as the mean±SEM. The 
results were analyzed or with repeated measures one or 
two-way ANOVA followed by Bonferroni post-test. The 
pD
2
 values were obtained by non-linear regression. All 
procedures were performed by using Graph Pad Prism 
3.02™
RESULTS AND DISCUSSION
 In Brazil, many hypertensive patients with 
associated cardiovascular diseases drink daily tea of 
Cymbopogon citratus, and this study demonstrated 
possible benefits of the essential oil extracted of this plant 
on the cardiovascular system. Our results demonstrated 
that OECC appears to have a calcium-blocking property 
as many drugs used in the treatment of hypertension such 
as amilodipine, nifedipine and verapamil (Sociedade 
Brasileira de Cardiologia, 2007).
 The analysis of the EOCC by GC/MS 
demonstrated the presence of eight constituents that are 
showed in Table 1. The major constituents were geranial 
(43.08%), neral (32.19%) and mircene (17.58%) (Table 1). 
The percentages obtained in the present work were similar 
to those demonstrated in other studies for the same species 
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(Blanco et al., 2009; Guimarães et al., 2008). Furthermore, 
it did not find in the literature any study demonstrating 
the activity of these constituents on the cardiovascular 
system.
 In non-anesthetized rats, the injections of EOCC 
(1, 5, 10 and 20 mg/kg; i.v.) induced an intense and tran-
sitory hypotension associated with bradycardia (Figure 
1A). 
 It is established that the stimulation of cardiac 
muscarinic receptors from sinoatrial node by vagal action 
induces intense bradycardia, which can be followed by 
hypotension due to a decrease in cardiac output (Peterson et 
al., 1984). It is also well known that activation of endothelial 
muscarinic receptors induces intense vasodilatation due to 
release of endothelium-derived relaxing factors, mainly 
NO and PGI
2
 (Furchgott & Zawadzki, 1980; Moncada 
& Higgs, 1993). This activation can cause decrease 
in peripheral vascular resistance and, consequently, 
hypotension. The involvement of the muscarinic receptors 
in these responses was evaluated through experiments in 
the animals pre-treated with atropine (2 mg/kg), a non-
selective antagonist of these receptors. In these animals, 
the hypotension was significantly attenuated only in dose 
of 20 mg/kg, while bradycardia was completely abolished 
in the doses of 5, 10 and 20 mg/kg (Figure 1A). This 
suggests that the bradycardia seems to be caused by cardiac 
muscarinic activation.
 In order to check a possible indirect effect of 
EOCC through of central nervous system and vagus nerve, 
we performed experiments by using rats anesthetized 
with sodium thiopental (45 mg/kg), a general anesthetic 
Table 1. Chemical composition of the essential oil of 
Cymbopogon citratus (DC.) Stapf, Poaceae, leaves
Constituents RI b %
6-Methyl-5-
hepten-2-one
982 0,57
Mircene 988 17,58
Linalool 1100 1,08
Epoxide of 
rosefurano
1170 0,51
Neral 1239 32,19
Geraniol 1251 4,37
Geranial 1269 43,08
Acetate of geraniol 1379 0,62
Total identified 100,00
a Percentages obtained by FID peak-area normalization 
(DB-5 column); b Retention Indices (DB-5 column)
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Figure 1. Hypotensive and bradycardic responses induced by in bolus administration of EOCC (1, 5, 10 and 20 mg/kg, i.v.) or vehicle 
in non-anesthetized rats: A. before (control) and after pretreatment with atropine (2 mg/kg, i.v., 15 min); B. before (control) and after 
pretreatment with L-NAME (20 mg/kg, i.v., 30 min) or INDO (5 mg/kg, i.v., 30 min). Values are mean±SEM of six experiments. To 
evaluate dose-dependence, it was used one-way ANOVA followed by Bonferroni post-test. To evaluate difference between groups, it 
was used repeated measures two-way ANOVA followed by Bonferroni post-test. *p<0.05, **p<0.01 and ***p<0.001 vs Control.
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with vagolitic and central vasomotor depressant actions 
(Morgan et al., 2006). In this condition, only bradycardia 
was significantly attenuated in the doses of 5, 10 and 
20 mg/kg (Figure 2), suggesting that, at least in part, 
the bradycardia induced by EOCC appears to involve 
components of central nervous system.
 Interestingly, despite the bradycardia has been 
completely abolished by atropine and attenuated by 
sodium thiopental, the hypotension induced by the doses 
of 5 and 10 mg/kg was not affected. Thus, the hypotension 
does not appear to be caused by decrease of cardiac output 
due to intense bradycardia and a possible decrease of the 
peripheral vascular resistance may also is contributing to 
the expression of this effect.
 A possible role of the NO and PGI
2
 in the EOCC-
induced hypotension was investigated. In animals treated 
with L-NAME (20 mg/kg), a nitric oxide (NO) synthase 
inhibitor (Moncada & Higgs, 1993) or INDO (5 mg/
kg), an inhibitor of cyclooxygenase (COX) (Furchgott & 
Zawadzki, 1980), the hypotension and bradycardia were 
not significantly altered (Figure 1B), suggesting that NO 
and PGI
2 
appear not be participating of these effects.
 To reinforce the hypothesis of that hypotensive 
response could be due to a decrease in peripheral vascular 
resistance caused by a possible vasorelaxation, we 
performed experiments in isolated rings of the rat superior 
mesenteric artery. In rings with intact endothelium, EOCC 
(1-3000 µg/mL) produced relaxations in concentration-
dependent manner of tonus induced by 10 μM of Phe (pD
2
 = 
2.52±0.10; Emax = 103±10%; n = 6). These vasorelaxations 
were not different of those obtained in the denuded-
endothelium rings (pD
2
 = 2.34±0.15; Emax =107±4%; n = 
6) (Figure 3A), suggesting that this effect appears not to be 
mediated by endothelium.
 These initial in vitro findings are in agreement 
with those obtained in the in vivo experiments, which 
demonstrated that hypotension induced by the EOCC 
appears not to be mediated by endothelial factors, such as 
NO or PGI
2
, but appears be caused by a vasodilatation. 
Furthermore, our results are analogous to others studies that 
had demonstrated that several essential oils present also 
a potent hypotensive effect through a direct vasorelaxant 
effect (Lahlou et al., 2005; Guedes et al., 2004).
 It well known that the maintenance of smooth 
muscle contraction depends on Ca2+ influx from extra-
cellular space through voltage and/or receptor operated 
calcium channels (VOCC and/or ROCC, respectively) 
(Karaki & Weiss, 1988). It is well also reported that the 
increase of external K+ concentration (KCl 80 mM) induces 
smooth muscle contraction through VOCC activation and 
subsequent calcium release from sarcoplasmic reticulum 
(Karaki & Weiss, 1988). The high K+-induced contraction 
is inhibited by Ca2+ channel blockers or by removal of 
external Ca2+. This contraction is, therefore, entirely 
dependent Ca2+ influx (Karaki & Weiss, 1988). Thus, 
we evaluated the EOCC effect on endothelium-denuded 
rings pre-contracted with K+-depolarizing solution (KCl 
80 mM). This set of experiments revealed that EOCC also 
induce vasorelaxations similarly to those obtained in rings 
pre-contracted with phenylephrine (pD
2
 = 2.04±0.12; Emax 
=101±7%; n = 6) (Figure 3B), which suggest that EOCC 
appears to be aging through the inhibition of the Ca+2 influx 
through VOCC.
 Furthermore, in preparations without endothelium 
pre-contracted with Phe, EOCC (1000 mg/mL) did not 
induce an additional effect on the maximal vasorelaxation 
of NIF (10 mM). Interestingly, the same was observed when 
NIF (10 mM) was added on the maximal vasorelaxation 
of the EOCC (1000 mg/mL) (Figure 4), demonstrating 
that EOCC could be acting through a similar pathway 
of NIF, i.e., blocking dihydropyridine sensitive L-type 
VOCC (Hagiwara et al., 1993). Although the results show 
a majority participation of the Ca+2 channels, the possible 
involvement of K+ channels can not be discarded.  
 According to the literature, potassium channels 
are the dominant ion conductive pathways in vascular 
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Figure 2. Hypotensive and bradycardic responses induced by 
in bolus administration of EOCC (1, 5, 10 and 20 mg/kg, i.v.) 
in non-anesthetized rats before and after sodium thiopental 
anesthesia (45 mg/kg, i.p., 30 min). Values are mean±SEM of 
six experiments. The data were analyzed with repeated measures 
two-way ANOVA followed by Bonferroni post-test. *p<0.05, 
**p<0.01 and ***p<0.001 vs Control.
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a non-selective blocker of these channels (Cook, 1989). 
In this condition, EOCC was able to induce relaxations 
(pD
2
 = 2.18±0.08; Emax = 105±4%; n = 6) that was not 
significantly different of the control (pD
2
 = 2.34±0.15; Emax 
= 107±4 %; n = 6) (Figure 3B). This result suggests that 
K+ channels do not seem to be involved in the vasorelaxant 
effect induced by the EOCC.
 Take together, these results demonstrate that the 
EOCC induces hypotension associated to bradycardia in 
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muscle cells. The electrochemical gradient for K+ ions is 
such that opening of K+ channels results in diffusion of this 
cation out of the cells and membrane hyperpolarization. 
This effect closes Ca2+ channels and leads to vasodilatation 
(Jackson, 2000).
 Thus, the participation of the K+ channels in the 
EOCC-induced vasorelaxation was investigated by using 
rings without functional endothelium, pre-contracted with 
Phe (10 µM), in the absence or presence of 100 µM of TEA, 
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Figure 3. Vasorelaxant effect of EOCC (1-3000 µg/mL, cumulatively) or vehicle in rings of rat superior mesenteric artery: A. pre-
contracted with Phe (10 µM) in the control condition (with endothelium) and after removal of endothelium; B. without endothelium 
pre-contracted with Phe (10 µM), pre-contracted with KCl 80 mM or pre-contracted with Phe (10 µM) after incubation with TEA 
(0.1 mM, 30 min). Values are mean±SEM of six experiments. The data were analyzed with one-way ANOVA followed by Bonferroni 
post-test.
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Figure 4. Vasorelaxant effect of NIF (10 mM), EOCC (1000 µg/ml), EOCC (1000 µg/ml) after the maximum relaxation of NIF (10 
mM) and NIF (10 mM) after the maximum relaxation of EOCC (1000 µg/mL) in rings of rat mesenteric artery without endothelium 
pre-contracted with Phe. Values are expressed as mean±SEM of six experiments. The data were analyzed with one-way ANOVA 
followed by Bonferroni post-test.
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normotensive non-anaesthetized rats. The hypotension 
appears to be caused by a decrease in peripheral vascular 
resistance, while bradycardia seems to be due to an 
activation of cardiac muscarinic receptors, involving, in 
part, compounds of central nervous system. Furthermore, 
the EOCC induces vasorelaxation in rat mesenteric artery 
possibly due to an inhibition of the Ca2+ influx through 
voltage-operated Ca2+ channels. This plant seems presents 
a potential clinical use for hypertension treatment, 
however, further studies are necessary to evaluate it safety 
and therapeutic margin before the human use.
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